thalidomide has been researched along with Adenopathy in 4 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Primary plasmacytomas are localized proliferations of clonal plasma cells occurring in the absence of a systemic plasma cell dyscrasia such as multiple myeloma." | 2.61 | Primary extramedullary plasmacytoma with diffuse lymph node involvement: a case report and review of the literature. ( Abdul-Hay, M; Naymagon, L, 2019) |
| "DLBCL rarely involves the orbit." | 1.48 | Sequential development of multifocal recurrent non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue and diffuse large B-Cell lymphoma in a single patient: A case report. ( He, W; Min, X; Yang, X, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kalantri, SA | 1 |
| Nath, UK | 1 |
| Banerjee, D | 1 |
| Bhattacharyya, M | 1 |
| Yang, X | 1 |
| Min, X | 1 |
| He, W | 1 |
| Naymagon, L | 1 |
| Abdul-Hay, M | 1 |
| Xiong, X | 1 |
| Ling, Y | 1 |
| Yang, K | 1 |
| Sun, W | 1 |
| Su, Z | 1 |
| Lu, Y | 1 |
1 review available for thalidomide and Adenopathy
| Article | Year |
|---|---|
Primary extramedullary plasmacytoma with diffuse lymph node involvement: a case report and review of the literature.
Topics: Aged; Bortezomib; Dexamethasone; Fatigue; Humans; Lymph Nodes; Lymphadenopathy; Male; Plasma Cells; | 2019 |
3 other studies available for thalidomide and Adenopathy
| Article | Year |
|---|---|
Case of lymphadenopathy with lytic bone lesions.
Topics: Bortezomib; Dexamethasone; Diagnosis, Differential; Humans; Incidental Findings; Lenalidomide; Lymph | 2017 |
Sequential development of multifocal recurrent non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue and diffuse large B-Cell lymphoma in a single patient: A case report.
Topics: Adult; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Hematop | 2018 |
Case of sarcoidosis presenting with symmetrical facial keratotic papules.
Topics: Cheek; Female; Hepatic Duct, Common; Humans; Keratosis; Lymph Nodes; Lymphadenopathy; Middle Aged; S | 2018 |